Clinical and structural alterations | Dup(15) autism | Idiopathic autism | |
---|---|---|---|
Autism prevalence and severity | Clinical data | 81Â % of subjects met criteria for autism and 92Â % for ASD [12, 14]. Autism diagnosed in 69Â % of subjects [36] | Mild 55Â %; Moderate 30Â %, Severe 15Â % [84] |
 | Postmortem study | Autism diagnosed in 89 % of children and young adults | 100 % |
Intellectual disability | Clinical data | IQ < 70, 31 %; IQ 71–85, 23 %; IQ > 85, 46 % [84] | |
 | Postmortem study | Profound, ID in 67 %; severe & moderate ID in 33 % | Moderate in 3 cases with tested IQ |
Epilepsy | Clinical data | Epilepsy in 63Â % [66] | Epilepsy in 33Â % [71]. Epileptiform activity in 31Â % of autistic children without epilepsy [75] |
 | Postmortem study | Epilepsy in 87 % including intractable epilepsy in 62 %. SUDEP in 87 % of cases | Epilepsy in 50 % of subjects SUDEP in one case/eight (12 %) |
Brain weight | Postmortem study | 1,215Â g | 1,611Â g (1,376Â g in control subjects) |
Focal developmental defects [46] | Heterotopias (alveus, CA4, DG) | 89 % | 10 % (p < 0.001) |
DG dysplasia | 89 % | 10 % (p < 0.001) | |
Cerebral cortical dysplasia | 0 % | 50 % (p < 0.03) | |
Cerebellar heterotopias | 56Â % | 60Â % (ns) | |
Cerebellar flocculus dysplasia | 75Â % | 50Â % (ns) | |
Subependymal nodular dysplasia | 22Â % | 10Â % (ns) | |
Neuronal soma volume deficit (compared to control in Wegiel et al. [60] and current study) | - | In 14/16 (87Â %) regions in 4 to 8 years old [60] | |
 |  | 11/25 (44 %) regions in 9 to 26 years old | In 3/16 (19 %) regions in 11 to 23 years old [60] |
 |  | - | In 4/16 (25 %) regions in 22 to 49 years old [60] |